Holocene Advisors’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-55,432
Closed -$18.1M – 883
2024
Q1
$18.1M Buy
+55,432
New +$13.6M 0.07% 221
2022
Q3
– Sell
-218,781
Closed -$41.8M – 984
2022
Q2
$41.8M Buy
218,781
+134,243
+159% +$23.7M 0.25% 122
2022
Q1
$17.5M Buy
+84,538
New +$13.9M 0.09% 195
2021
Q2
– Sell
-258,419
Closed -$33.7M – 960
2021
Q1
$33.7M Sell
258,419
-249,537
-49% -$29.9M 0.21% 134
2020
Q4
$52.7M Buy
507,956
+418,660
+469% +$36.3M 0.33% 110
2020
Q3
$6.77M Buy
+89,296
New +$5.06M 0.05% 245

Other funds holding SWAV

Holocene Advisors's SWAV Position: Q2 2024 in Review

Holocene Advisors sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 55,432 shares — an estimated $18.1M sold.

Holocene Advisors first reported a position in SWAV in Q3 2020 and held it in 6 quarters. The position peaked at $52.7M in Q4 2020. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Holocene Advisors reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • Holocene Advisors sold 55,432 Shockwave Medical shares in Q2 2024, an estimated $18.1M.
  • Holocene Advisors first reported a position in Shockwave Medical in Q3 2020 and held it in 6 quarters.
  • Holocene Advisors's Shockwave Medical position peaked at $52.7M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on Holocene Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.